Trials / Conditions / Pelvic Inflammatory Disease

Pelvic Inflammatory Disease

24 registered clinical trials studyying Pelvic Inflammatory Disease — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	The Diagnostic Utility of Ultrasound in Pelvic Inflammatory Disease (PID) NCT06756568	Superior University	—
Recruiting	Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pe NCT06360965	Beijing Hospital of Integrated Traditional Chinese and Western Medicine	N/A
Unknown	Pelvic Inflammatory Disease in COVID-19 Era NCT05648747	Università degli Studi di Ferrara	—
Unknown	Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses NCT05408624	Nantes University Hospital	—
Completed	Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases NCT04723069	University of Karachi	Phase 2
Recruiting	Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer NCT04567771	Mayo Clinic	N/A
Unknown	Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity NCT04234945	Ahmadu Bello University Teaching Hospital	N/A
Active Not Recruiting	Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II NCT03828994	Johns Hopkins University	N/A
Completed	Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer NCT03994055	National Institute of Cancerología	N/A
Completed	First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics NCT03054402	Bayer	Phase 1
Unknown	Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae NCT02972151	Shanghai University of Traditional Chinese Medicine	Phase 2
Unknown	A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease NCT03391440	Jiangsu Hansoh Pharmaceutical Co., Ltd.	Phase 4
Completed	Surgical Success After Laparoscopic vs Abdominal Hysterectomy NCT01793584	University of Texas Southwestern Medical Center	N/A
Completed	Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Market NCT01671280	Pfizer	—
Completed	Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease NCT01299259	Children's Hospital of Philadelphia	N/A
Completed	The Role of Novel Organisms in Acute Endometritis NCT01236131	Sharon Hillier	—
Completed	The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) NCT01160640	Harold Wiesenfeld	Phase 2
Completed	Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Ran NCT01799356	Istanbul Bakirkoy Maternity and Children Diseases Hospital	Phase 4
Completed	To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment NCT01241110	Guilan University of Medical Sciences	Phase 4
Completed	Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan NCT00871494	Pfizer	Phase 3
Completed	Rate of Pelvic Inflammatory Disease at St. Michael's Hospital NCT00783419	Unity Health Toronto	—
Completed	A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Dis NCT00453349	Bayer	Phase 3
Completed	Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease NCT00115388	St George's, University of London	N/A
Completed	Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin. NCT00683865	Bayer	Phase 3